David Koos
Algemeen Directeur bij REGEN BIOPHARMA, INC.
Vermogen: 253 049 $ op 30-04-2024
Actieve functies van David Koos
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REGEN BIOPHARMA, INC. | Algemeen Directeur | 24-04-2012 | - |
| Voorzitter | 24-04-2012 | - | |
| Financieel Directeur/CFO | - | - | |
| Comptroller/Controller/Auditor | 24-04-2012 | - | |
| President | 29-05-2013 | 30-04-2015 | |
| Bedrijfssecretaris | 24-04-2012 | - | |
| Treasurer | 24-04-2012 | - | |
| BST Partners, Inc. | Algemeen Directeur | 30-11-2018 | - |
| Voorzitter | 30-11-2018 | - | |
| Kcl Therapeutics, Inc. | Algemeen Directeur | 23-03-2021 | - |
| Voorzitter | 23-03-2021 | - | |
| President | 23-03-2021 | - | |
| Bedrijfssecretaris | 23-03-2021 | - | |
| Treasurer | 23-03-2021 | - | |
| AFN Trust | Directeur/Bestuurslid | - | - |
| BMXP Holdings Shareholders Business Trust | Directeur/Bestuurslid | - | - |
| Cell Source Research, Inc. | Directeur/Bestuurslid | 24-03-2003 | - |
| Algemeen Directeur | 24-03-2003 | - | |
| President | 24-03-2003 | - | |
| Venture Bridge, Inc. | Algemeen Directeur | 21-11-2001 | - |
| President | 21-11-2001 | - |
Loopbaan van David Koos
Eerdere bekende functies van David Koos
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SYBLEU INC. | Algemeen Directeur | 12-06-2020 | 13-12-2022 |
| Voorzitter | 12-06-2020 | 13-12-2022 | |
| Financieel Directeur/CFO | 12-06-2020 | 21-07-2020 | |
| President | 12-06-2020 | 13-12-2022 | |
| Bedrijfssecretaris | 12-06-2020 | 13-12-2022 | |
| Treasurer | 12-06-2020 | 13-12-2022 | |
Zander Therapeutics, Inc.
 Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zander Therapeutics, Inc. engages in the development and commercialization of veterinary medical therapies. It focuses on developing small molecule immunotherapies and cancer stem cell therapies for the veterinary market. The company was founded on July 18, 2015 and is headquartered in La Mesa, CA. | Algemeen Directeur | 18-06-2015 | 22-01-2020 |
| Voorzitter | 18-06-2015 | 22-01-2020 | |
| Financieel Directeur/CFO | 18-06-2015 | 01-02-2017 | |
| President | 18-06-2015 | 01-02-2017 | |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░ ░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
| ░░░░░░░░░ | - | - |
Opleiding van David Koos
| University of California, Riverside | Graduate Degree |
| Atlantic International University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 22 |
| China | 2 |
Operationeel
| President | 15 |
| Chairman | 14 |
| Chief Executive Officer | 11 |
Sectoraal
| Health Technology | 7 |
| Finance | 3 |
| Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| RIVULET MEDIA, INC. | Technology Services |
| ENTEST GROUP, INC. | Finance |
| REGEN BIOPHARMA, INC. | Health Technology |
| SYBLEU INC. | Commercial Services |
| Bedrijven in privébezit | 16 |
|---|---|
| Tasco Holdings International, Inc. | Finance |
Frezer, Inc.
 Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | Health Technology |
Freedom Environmental Services, Inc.
 Freedom Environmental Services, Inc. Miscellaneous Commercial ServicesCommercial Services Freedom Environmental Services, Inc. provided waste water and storm-water system management, grease and organics collection and disposition, and commercial plumbing and water system management to the commercial and industrial customers. The company was founded on October 6, 1978 and is headquartered in Orlando, FL. | Commercial Services |
| BEFUT International Co. Ltd. /Old/ | Producer Manufacturing |
JB Clothing Corp.
 JB Clothing Corp. Apparel/Footwear RetailRetail Trade JB Clothing Corp. designs and manufactures women's fashion apparels. It manufactures and markets shorts, tops, Tees, and hats. It was founded on September 24, 2008 and is headquartered in Las Vegas, NV. | Retail Trade |
| Venture Bridge, Inc. | |
| Cell Source Research, Inc. | |
Cell Bio-Systems, Inc.
 Cell Bio-Systems, Inc. Medical SpecialtiesHealth Technology Cell Bio-Systems, Inc. developed medical devices and patented technologies for the living tissue markets, including plastic, cosmetic, and orthopedic surgeries. The company was headquartered in San Diego, CA. | Health Technology |
| BMXP Holdings, Inc. | Health Technology |
| BMXP Holdings Shareholders Business Trust | |
| AFN Trust | |
Zander Therapeutics, Inc.
Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zander Therapeutics, Inc. engages in the development and commercialization of veterinary medical therapies. It focuses on developing small molecule immunotherapies and cancer stem cell therapies for the veterinary market. The company was founded on July 18, 2015 and is headquartered in La Mesa, CA. | Health Technology |
| Kcl Therapeutics, Inc. | |
| Entest BioMedical, Inc. /Old/ | Health Technology |
| BST Partners, Inc. | |
| BST Partners, Inc. (Wyoming) |
- Beurs
- Insiders
- David Koos
- Ervaring